APA (7th ed.) Citation

Ilteris Oguz Topal, Sevim Baysak, İlknur Kıvanç Altunay, Asude Kara Polat, Eylem Emel Arıkan, Ezgi Özkur, . . . Ayșe Serap Karadaǧ. (2022). Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: Real-world data from a retrospective multicenter study. Sociedade Brasileira de Dermatologia.

Chicago Style (17th ed.) Citation

Ilteris Oguz Topal, et al. Evaluation of the Efficacy, Safety, and Side Effects of Secukinumab in Patients with Moderate-to-severe Psoriasis: Real-world Data from a Retrospective Multicenter Study. Sociedade Brasileira de Dermatologia, 2022.

MLA (9th ed.) Citation

Ilteris Oguz Topal, et al. Evaluation of the Efficacy, Safety, and Side Effects of Secukinumab in Patients with Moderate-to-severe Psoriasis: Real-world Data from a Retrospective Multicenter Study. Sociedade Brasileira de Dermatologia, 2022.